These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30139748)

  • 21. Macrophages escape Klotho gene silencing in the mdx mouse model of Duchenne muscular dystrophy and promote muscle growth and increase satellite cell numbers through a Klotho-mediated pathway.
    Wehling-Henricks M; Welc SS; Samengo G; Rinaldi C; Lindsey C; Wang Y; Lee J; Kuro-O M; Tidball JG
    Hum Mol Genet; 2018 Jan; 27(1):14-29. PubMed ID: 29040534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function.
    Ermolova NV; Martinez L; Vetrone SA; Jordan MC; Roos KP; Sweeney HL; Spencer MJ
    Neuromuscul Disord; 2014 Jul; 24(7):583-95. PubMed ID: 24844454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
    Tsuchida K
    Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.
    Morine KJ; Bish LT; Pendrak K; Sleeper MM; Barton ER; Sweeney HL
    PLoS One; 2010 Feb; 5(2):e9176. PubMed ID: 20161803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
    Timpani CA; Goodman CA; Stathis CG; White JD; Mamchaoui K; Butler-Browne G; Gueven N; Hayes A; Rybalka E
    Sci Rep; 2020 Jan; 10(1):1125. PubMed ID: 31980663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.
    Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ
    Hum Mol Genet; 2015 Apr; 24(8):2147-62. PubMed ID: 25552658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with rGDF11 does not improve the dystrophic muscle pathology of mdx mice.
    Rinaldi F; Zhang Y; Mondragon-Gonzalez R; Harvey J; Perlingeiro RCR
    Skelet Muscle; 2016; 6():21. PubMed ID: 27303621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation.
    Sun Z; Xu D; Zhao L; Li X; Li S; Huang X; Li C; Sun L; Liu B; Jiang Z; Zhang L
    Br J Pharmacol; 2022 Mar; 179(6):1237-1250. PubMed ID: 34553378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Wehling-Henricks M; Li Z; Lindsey C; Wang Y; Welc SS; Ramos JN; Khanlou N; Kuro-O M; Tidball JG
    Hum Mol Genet; 2016 Jun; 25(12):2465-2482. PubMed ID: 27154199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
    Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP
    Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.
    Abou-Khalil R; Yang F; Mortreux M; Lieu S; Yu YY; Wurmser M; Pereira C; Relaix F; Miclau T; Marcucio RS; Colnot C
    J Bone Miner Res; 2014 Feb; 29(2):304-15. PubMed ID: 23857747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
    Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
    Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of myostatin reverses muscle fibrosis through apoptosis.
    Bo Li Z; Zhang J; Wagner KR
    J Cell Sci; 2012 Sep; 125(Pt 17):3957-65. PubMed ID: 22685331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.